Publication | Closed Access

Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer—biweekly versus standard triweekly XELOX (The ORION Study)

Gastrointestinal OncologyMedicineColorectal CancerSurgeryOxaliplatin ReintroductionCancer TreatmentOncologyRadiation OncologyMolecular OncologyOrion StudyLater-line Therapy